找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Oral Delivery of Macromolecular Drugs; Barriers, Strategies Andreas Bernkop-Schnürch Book 2009 Springer-Verlag New York 2009 Barriers.Bernk

[復(fù)制鏈接]
樓主: APL
41#
發(fā)表于 2025-3-28 18:17:49 | 只看該作者
42#
發(fā)表于 2025-3-28 18:46:25 | 只看該作者
Low Molecular Mass Permeation Enhancers in Oral Delivery of Macromolecular Drugs,permeation enhancers in mind and taking all the opportunities ahead into consideration, this class of permeation enhancers will certainly further alter the landscape of drug delivery towards more efficient therapeutic systems.
43#
發(fā)表于 2025-3-29 02:59:43 | 只看該作者
Multifunctional Polymeric Excipients in Oral Macromolecular Drug Delivery,n provide high drug concentrations at the target site and tight contact with the absorption membrane due to mucoadhesion. Furthermore, sustained or delayed release due to cohesive properties of the polymeric carrier system offers new possibilities for targeted macromolecular drug delivery.
44#
發(fā)表于 2025-3-29 05:54:58 | 只看該作者
Liposome-Based Mucoadhesive Formulations for Oral Delivery of Macromolecules,n) was observed after oral administration. In most cases, the polymer-coated liposomes and/or polymer–liposome complexes showed superior pharmacological action compared to other systems without mucoadhesive polymers.
45#
發(fā)表于 2025-3-29 07:50:01 | 只看該作者
Nano- and Microparticles in Oral Delivery of Macromolecular Drugs,ilicity. Particles’ properties such as membrane-passing properties, permeation-enhancing properties, mucoadhesive properties, and protective properties are extensively discussed. Furthermore, evidence for the potential of such systems is provided with examples from recent in vivo studies.
46#
發(fā)表于 2025-3-29 13:47:26 | 只看該作者
47#
發(fā)表于 2025-3-29 16:00:48 | 只看該作者
Book 2009ther advanced research and clinical application. However, the delivery of these macromolecular drugs by routes other than the parenteral route is difficult. The pipeline of macromolecular drugs derived from biotechnology presents a challenging opportunity to develop practical dosage forms that could
48#
發(fā)表于 2025-3-29 20:51:45 | 只看該作者
Gastrointestinal Mucus Gel Barrier, the usefulness of orally administered drugs. In this chapter, I review the molecular and cellular properties of gel-forming mucins and how these macromolecules are organized into a tri-dimensional network to form the gastrointestinal mucus gel barrier.
49#
發(fā)表于 2025-3-30 00:21:56 | 只看該作者
Strategies to Overcome Efflux Pumps,everal drugs across the intestine..In this chapter, several efflux pump inhibitors such as low molecular mass inhibitors, polymeric inhibitors and advanced formulation approaches on how to overcome drug efflux are discussed.
50#
發(fā)表于 2025-3-30 04:50:14 | 只看該作者
Strategies in Oral Immunization,s is one approach which enables the production of highly customized all-in-one self-adjuvanting vaccines. Lipid-modified peptide vaccines have been successfully investigated in humans and demonstrated to be potent and more importantly very safe.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 14:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
天峨县| 兴义市| 分宜县| 安溪县| 疏勒县| 泰来县| 通江县| 历史| 松滋市| 大竹县| 梅河口市| 天等县| 西宁市| 安塞县| 泾源县| 西吉县| 白沙| 高雄市| 康马县| 交城县| 新沂市| 临猗县| 大同市| 康定县| 乌海市| 兴宁市| 黎城县| 通江县| 达日县| 广德县| 乌兰县| 大兴区| 江永县| 通渭县| 洛阳市| 合山市| 罗江县| 万山特区| 竹北市| 石柱| 行唐县|